marijuana stocks news

Form 8-K for LEXARIA CORP.


27-Apr-2016

Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of PrincipalEffective April 29, 2016, Ms. Bal Bhullar will be resigning as Chief Financial Officer and Director from Lexaria and Lexaria’s subsidiaries.

Mr. Chris Bunka will become interim Chief Financial Officer until a replacement is filled for that position once Ms. Bal Bhullar has resigned.

Effective April 29, 2016, the Board will appoint Mr. John Docherty as director of the Company.

 

Item 7.01 Regulation FD Disclosure.A copy of the news release is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.(d) Exhibits.

Exhibit No. Description

99.1 Press Release dated April 27, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$EAPH Announces the Appointment of Evan Karras as CEO

Easton Pharmaceuticals Announces the Appointment of Evan Karras as CEO / Director…

Cara Therapeutics, Inc. (CARA) Announces Initiation of Phase 2 Trial of Oral KORSUVA™

Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin)…

$NTRR CEO Issues Letter to Shareholders Detailing Plans for New Year

NTRR CEO Issues Letter to Shareholders Detailing Plans for New Year Neutra…